What does Instil Bio, Inc. do?
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in…
What is Instil Bio, Inc.'s P/E and P/B ratio?
Instil Bio, Inc. has a P/E ratio of -1.3 and a P/B ratio of 0.36.
What is Instil Bio, Inc.'s debt-to-equity ratio?
Instil Bio, Inc. has a debt-to-equity ratio of 0.81.
How much does Instil Bio, Inc. owe compared with what it owns?
Instil Bio, Inc. owes $0.46 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Instil Bio, Inc.'s Positivity rank?
Instil Bio, Inc. is ranked #2,318 of 6,774 companies globally and #700 of 4,000 in United States on PositoAI, with a Positivity Score of 21,650.
Does Instil Bio, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Instil Bio, Inc. has no active red flags. It has 1 yellow flag (PosiYellow stress signals, 2/10 points): Change of auditor (8-K Item 4.01).
Where can I read the latest news about Instil Bio, Inc.?
Recent headlines about Instil Bio, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Instil Bio, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Instil Bio, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.